Lilly has a new blockbuster
World of DTC Marketing
MAY 16, 2022
Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. Will patients, who are obese and don’t have Type 2 diabetes, ask for the drug for weight loss, and will patients understand the risks? Will patients look past those side effects to lose weight? A matter of trust?
Let's personalize your content